HemaSphere (Jun 2022)

PB2056: MYELOFIBROSIS IN PATIENTS OLDER THAN 70 YEARS: IS TREATMENT WITH RUXOLITINIB WORTH IT?

  • M. I. Montero

DOI
https://doi.org/10.1097/01.HS9.0000851056.70678.c8
Journal volume & issue
Vol. 6
pp. 1927 – 1928

Abstract

Read online

No abstracts available.